Furthermore, HER2 is a transmembrane receptor with tyrosine kinase activity associated with cell proliferation, survival, metastasis, and drug resistance, and its overexpression is frequently seen in various types of human cancers, such as bladder cancer. The gene discussed is ERBB2; the disease is urinary bladder carcinoma.